Zay Washington—a lead trainer at Taylor Swift's longtime gym Dogpound—knows when an exerciser is going to be trouble when ...

Structure Therapeutics (NASDAQ:GPCR), and Terns Pharmaceuticals (NASDAQ:TERN), which are all developing oral pills as weight loss treatments, are trading higher Friday following disappointing results ...

Artificial heart maker Carmat on Wednesday announced the launch of a new capital increase for an initial amount of 10.3 ...

This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so ...

Half a century of advancements in biomedical science paved the way for today’s powerful weight-loss drugs like Ozempic — so ...

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

Poring over the hormone's structure, she correctly predicted the ... on these breakthroughs to develop treatments for diabetes (Ozempic) and obesity (Wegovy), extending the drug's therapeutic ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

A short time later, Isaacman swung open the hatch and climbed through, gripping the hand and footholds of a structure known as "Skywalker," as a breathtaking view of Earth unfolded below him.